These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8846128)
1. Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin. McCowage GB; Frush DP; Kurtzberg J J Pediatr Hematol Oncol; 1996 May; 18(2):154-8. PubMed ID: 8846128 [TBL] [Abstract][Full Text] [Related]
2. Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature. Weitzman S; Wayne AS; Arceci R; Lipton JM; Whitlock JA Med Pediatr Oncol; 1999 Nov; 33(5):476-81. PubMed ID: 10531572 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Langerhans cell histiocytosis with 2'-deoxycoformycin (2'-DCF). Lombardi A; Caniglia M; Longo D; Rana I; Pinto RM; Caruso R; Russo LA; De Rossi G Hematol J; 2002; 3(2):118-9. PubMed ID: 12032875 [No Abstract] [Full Text] [Related]
4. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Stine KC; Saylors RL; Williams LL; Becton DL Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735 [TBL] [Abstract][Full Text] [Related]
5. [Treatment results of Langerhans cell histiocytosis with LSH II protocol]. Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702 [TBL] [Abstract][Full Text] [Related]
6. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540 [TBL] [Abstract][Full Text] [Related]
7. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Minkov M Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807 [TBL] [Abstract][Full Text] [Related]
8. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases. Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539 [TBL] [Abstract][Full Text] [Related]
9. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up. Seymour JF; Talpaz M; Kurzrock R Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India. Narula G; Pradhan ND; Arora B; Banavali SD Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864 [TBL] [Abstract][Full Text] [Related]
11. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]. Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704 [TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine. Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine therapy for refractory Langerhans cell histiocytosis. Aricò M; Colella R; Conter V; Indolfi P; Pession A; Santoro N; Burgio GR Med Pediatr Oncol; 1995 Jul; 25(1):12-6. PubMed ID: 7752996 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation for refractory Langerhans' cell histiocytosis. Conter V; Reciputo A; Arrigo C; Bozzato N; Sala A; Aricò M Haematologica; 1996; 81(5):468-71. PubMed ID: 8952163 [TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489 [TBL] [Abstract][Full Text] [Related]
17. A child with pulmonary and liver Langerhans'-cell histiocytosis. Ma XL; Shen KL; Wang B Chin Med J (Engl); 2012 May; 125(9):1675-6. PubMed ID: 22800845 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Langerhans cell histiocytosis in children with etoposide. Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115 [TBL] [Abstract][Full Text] [Related]
19. Adult Langerhans' cell histiocytosis with multisystem involvement: A case report. Kim SS; Hong SA; Shin HC; Hwang JA; Jou SS; Choi SY Medicine (Baltimore); 2018 Nov; 97(48):e13366. PubMed ID: 30508929 [TBL] [Abstract][Full Text] [Related]
20. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]